May 19, 2020 / 02:50PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Hello. Welcome to another morning session at day 2 of the UBS Global Healthcare Conference. I'm Dan Brennan. I cover tools, diagnostics, pharma services. I'm pleased to be joined with me in this virtual meeting with senior management from Bruker Corp. Without any introduction needed, we have Frank Laukien, Chairman, President and CEO; and also on the phone is Miroslava Minkova, who is the Head of IR.
So first off, thank you both for being here. And I think the approach will be, Frank is going to provide some opening remarks for a bit, and then we'll get into Q&A. And anyone dialed into the webcast or going through the computer, please feel free to pose any questions you'd like on the computer and I can see them pop up on my screen. So with no further ado, Frank?
Frank H. Laukien - Bruker Corporation - Chairman, CEO & President
Thank you very much, Dan. Thanks for having us on the UBS Virtual Global Healthcare Conference.
Bruker Corp at UBS Global Healthcare Conference (Virtual) Transcript
May 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers